| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.714 | 0.004 | 0.714 | DNA synthesis inhibitor | 0.691 0.005 DBMET03427 | ||
| 0.562 | 0.003 | 0.562 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.517 0.004 DBMET03427 | ||
| 0.564 | 0.009 | 0.564 | Vasodilator, coronary | 0.533 0.012 DBMET03427 | ||
| 0.555 | 0.02 | 0.555 | Vasodilator, peripheral | 0.524 0.024 DBMET03427 | ||
| 0.537 | 0.003 | 0.638 | NADH dehydrogenase inhibitor | 0.638 0.002 DBMET03427 | DBMET03427 | |
| 0.522 | 0.003 | 0.549 | Adenosine A1 receptor antagonist | 0.549 0.003 DBMET03427 | DBMET03427 | |
| 0.546 | 0.046 | 0.564 | Caspase 9 stimulant | 0.564 0.042 DBMET03427 | DBMET03427 | |
| 0.51 | 0.01 | 0.55 | RNA-directed DNA polymerase inhibitor | 0.55 0.008 DBMET03427 | DBMET03427 | |
| 0.462 | 0.003 | 0.478 | Adenosine A3 receptor antagonist | 0.478 0.003 DBMET03427 | DBMET03427 | |
| 0.484 | 0.031 | 0.484 | Immunostimulant | 0.456 0.036 DBMET03427 | ||
| 0.414 | 0.002 | 0.442 | Phosphoglycerate kinase inhibitor | 0.442 0.001 DBMET03427 | DBMET03427 | |
| 0.415 | 0.005 | 0.474 | UDP-glucose 4-epimerase inhibitor | 0.474 0.003 DBMET03427 | DBMET03427 | |
| 0.44 | 0.033 | 0.511 | Immunomodulator | 0.511 0.022 DBMET03427 | DBMET03427 | |
| 0.378 | 0.004 | 0.399 | Uric acid excretion stimulant | 0.399 0.004 DBMET03427 | DBMET03427 | |
| 0.378 | 0.004 | 0.515 | Adenosine A2a receptor antagonist | 0.515 0.003 DBMET03427 | DBMET03427 | |
| 0.403 | 0.049 | 0.488 | Cholesterol antagonist | 0.488 0.034 DBMET03427 | DBMET03427 | |
| 0.358 | 0.004 | 0.368 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.368 0.004 DBMET03427 | DBMET03427 | |
| 0.35 | 0.005 | 0.35 | Aminoacyl-tRNA synthetase inhibitor | 0.346 0.005 DBMET03427 | ||
| 0.349 | 0.004 | 0.472 | Adenosine A2 receptor antagonist | 0.472 0.003 DBMET03427 | DBMET03427 | |
| 0.337 | 0.013 | 0.337 | Alpha-N-acetylglucosaminidase inhibitor | 0.257 0.022 DBMET03427 | ||
| 0.347 | 0.03 | 0.384 | Interleukin agonist | 0.384 0.021 DBMET03427 | DBMET03427 | |
| 0.32 | 0.012 | 0.411 | Adenylate cyclase inhibitor | 0.411 0.007 DBMET03427 | DBMET03427 | |
| 0.385 | 0.084 | 0.505 | Antibacterial | 0.505 0.039 DBMET03427 | DBMET03427 | |
| 0.316 | 0.019 | 0.328 | Peptidyltransferase inhibitor | 0.328 0.016 DBMET03427 | DBMET03427 | |
| 0.306 | 0.018 | 0.424 | Cytidine deaminase inhibitor | 0.424 0.009 DBMET03427 | DBMET03427 | |
| 0.366 | 0.078 | 0.369 | Immunosuppressant | 0.369 0.077 DBMET03427 | DBMET03427 | |
| 0.31 | 0.025 | 0.43 | DNA methylase inhibitor | 0.43 0.009 DBMET03427 | DBMET03427 | |
| 0.33 | 0.055 | 0.351 | Interleukin 2 agonist | 0.351 0.045 DBMET03427 | DBMET03427 | |
| 0.312 | 0.037 | 0.401 | Cyclic AMP phosphodiesterase inhibitor | 0.401 0.016 DBMET03427 | DBMET03427 | |
| 0.282 | 0.013 | 0.338 | Topoisomerase I inhibitor | 0.338 0.008 DBMET03427 | DBMET03427 | |
| 0.259 | 0.016 | 0.34 | DNA polymerase I inhibitor | 0.34 0.009 DBMET03427 | DBMET03427 | |
| 0.247 | 0.005 | 0.411 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.411 0.002 DBMET03427 | DBMET03427 | |
| 0.254 | 0.027 | 0.337 | Amylase inhibitor | 0.337 0.014 DBMET03427 | DBMET03427 | |
| 0.303 | 0.077 | 0.381 | Caspase 3 stimulant | 0.381 0.05 DBMET03427 | DBMET03427 | |
| 0.221 | 0.025 | 0.36 | Hexokinase inhibitor | 0.36 0.005 DBMET03427 | DBMET03427 | |
| 0.329 | 0.139 | 0.335 | Cyclophilin D inhibitor | 0.335 0.134 DBMET03427 | DBMET03427 | |
| 0.239 | 0.052 | 0.324 | DNA methyltransferase I inhibitor | 0.324 0.019 DBMET03427 | DBMET03427 | |
| 0.28 | 0.1 | 0.293 | Apoptosis antagonist | 0.293 0.09 DBMET03427 | DBMET03427 | |
| 0.189 | 0.009 | 0.189 | Heat shock protein 70 antagonist | 0.188 0.009 DBMET03427 | ||
| 0.183 | 0.013 | 0.338 | Phosphofructokinase-1 inhibitor | 0.338 0.004 DBMET03427 | DBMET03427 | |
| 0.183 | 0.018 | 0.316 | Adenylate kinase inhibitor | 0.316 0.006 DBMET03427 | DBMET03427 | |
| 0.175 | 0.016 | 0.367 | AMP-activated protein kinase stimulant | 0.367 0.004 DBMET03427 | DBMET03427 | |
| 0.174 | 0.016 | 0.304 | DNA repair enzyme inhibitor | 0.304 0.004 DBMET03427 | DBMET03427 | |
| 0.164 | 0.011 | 0.267 | Antimetabolite | 0.267 0.006 DBMET03427 | DBMET03427 | |
| 0.157 | 0.007 | 0.203 | Phosphorylase inhibitor | 0.203 0.005 DBMET03427 | DBMET03427 | |
| 0.158 | 0.01 | 0.277 | Carbamoyl phosphate synthetase inhibitor | 0.277 0.005 DBMET03427 | DBMET03427 | |
| 0.31 | 0.165 | 0.331 | Apoptosis agonist | 0.331 0.151 DBMET03427 | DBMET03427 | |
| 0.175 | 0.035 | 0.175 | Aldehyde dehydrogenase inhibitor | 0.17 0.037 DBMET03427 | ||
| 0.206 | 0.068 | 0.21 | Platelet adhesion inhibitor | 0.21 0.066 DBMET03427 | DBMET03427 | |
| 0.219 | 0.085 | 0.239 | Angiogenesis stimulant | 0.239 0.075 DBMET03427 | DBMET03427 | |
| 0.169 | 0.036 | 0.191 | Adenylate cyclase stimulant | 0.191 0.018 DBMET03427 | DBMET03427 | |
| 0.253 | 0.125 | 0.31 | Transcription factor NF kappa B inhibitor | 0.31 0.089 DBMET03427 | DBMET03427 | |
| 0.136 | 0.013 | 0.22 | Argininosuccinate synthase inhibitor | 0.22 0.007 DBMET03427 | DBMET03427 | |
| 0.169 | 0.047 | 0.169 | Cyclin-dependent kinase 7 inhibitor | 0.102 0.098 DBMET03427 | ||
| 0.146 | 0.026 | 0.146 | Transcription factor STAT6 inhibitor | 0.138 0.035 DBMET03427 | ||
| 0.173 | 0.054 | 0.197 | Protein kinase stimulant | 0.197 0.043 DBMET03427 | DBMET03427 | |
| 0.122 | 0.011 | 0.156 | Purinergic P2X1 antagonist | 0.156 0.006 DBMET03427 | DBMET03427 | |
| 0.111 | 0.004 | 0.137 | Adenosine A1 receptor agonist | 0.137 0.003 DBMET03427 | DBMET03427 | |
| 0.126 | 0.021 | 0.233 | Glutamate dehydrogenase inhibitor | 0.233 0.008 DBMET03427 | DBMET03427 | |
| 0.123 | 0.019 | 0.13 | Purinergic P2X2 antagonist | 0.13 0.017 DBMET03427 | DBMET03427 | |
| 0.099 | 0.003 | 0.099 | Adenosine A2 receptor agonist | 0.084 0.003 DBMET03427 | ||
| 0.203 | 0.109 | 0.218 | Hypoglycemic | 0.218 0.098 DBMET03427 | DBMET03427 | |
| 0.199 | 0.105 | 0.199 | Vasodilator | 0.199 0.105 DBMET03427 | ||
| 0.118 | 0.026 | 0.118 | Transcription factor NF kappa B stimulant | 0.117 0.027 DBMET03427 | ||
| 0.09 | 0.007 | 0.125 | Thymidine kinase inhibitor | 0.125 0.005 DBMET03427 | DBMET03427 | |
| 0.094 | 0.011 | 0.162 | Adenosine A2b receptor antagonist | 0.162 0.005 DBMET03427 | DBMET03427 | |
| 0.084 | 0.008 | 0.119 | Adenosine deaminase inhibitor | 0.119 0.004 DBMET03427 | DBMET03427 | |
| 0.293 | 0.222 | 0.293 | Antiinflammatory | |||
| 0.09 | 0.022 | 0.211 | Biliverdin reductase inhibitor | 0.211 0.005 DBMET03427 | DBMET03427 | |
| 0.12 | 0.054 | 0.128 | Mucolytic | 0.128 0.048 DBMET03427 | DBMET03427 | |
| 0.083 | 0.02 | 0.12 | Ornithine carbamoyltransferase inhibitor | 0.12 0.013 DBMET03427 | DBMET03427 | |
| 0.079 | 0.016 | 0.084 | Glucosylceramidase inhibitor | 0.084 0.013 DBMET03427 | DBMET03427 | |
| 0.098 | 0.038 | 0.098 | Hematopoietic | 0.084 0.062 DBMET03427 | ||
| 0.142 | 0.083 | 0.142 | Insulin secretagoues | |||
| 0.144 | 0.086 | 0.159 | Interferon gamma antagonist | 0.159 0.067 DBMET03427 | DBMET03427 | |
| 0.107 | 0.049 | 0.129 | DNA directed RNA polymerase inhibitor | 0.129 0.032 DBMET03427 | DBMET03427 | |
| 0.154 | 0.098 | 0.189 | Phospholipase C inhibitor | 0.189 0.052 DBMET03427 | DBMET03427 | |
| 0.148 | 0.092 | 0.154 | Interleukin 6 antagonist | 0.154 0.083 DBMET03427 | DBMET03427 | |
| 0.081 | 0.026 | 0.086 | Ribonucleotide reductase inhibitor | 0.086 0.024 DBMET03427 | DBMET03427 | |
| 0.069 | 0.016 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET03427 | DBMET03427 | |
| 0.056 | 0.005 | 0.088 | Sodium/glucose cotransporter 2 inhibitor | 0.088 0.004 DBMET03427 | DBMET03427 | |
| 0.063 | 0.013 | 0.113 | AICAR transformylase inhibitor | 0.113 0.004 DBMET03427 | DBMET03427 | |
| 0.098 | 0.047 | 0.098 | Phosphodiesterase I inhibitor | 0.079 0.078 DBMET03427 | ||
| 0.084 | 0.034 | 0.092 | Selectin antagonist | 0.092 0.031 DBMET03427 | DBMET03427 | |
| 0.049 | 0.003 | 0.049 | Adenosine A2a receptor agonist | 0.048 0.003 DBMET03427 | ||
| 0.062 | 0.016 | 0.098 | Thymidylate synthase inhibitor | 0.098 0.004 DBMET03427 | DBMET03427 | |
| 0.051 | 0.006 | 0.108 | Adenosine kinase inhibitor | 0.108 0.003 DBMET03427 | DBMET03427 | |
| 0.134 | 0.092 | 0.179 | NOS3 expression enhancer | 0.179 0.05 DBMET03427 | DBMET03427 | |
| 0.209 | 0.167 | 0.234 | Antithrombotic | 0.234 0.14 DBMET03427 | DBMET03427 | |
| 0.069 | 0.027 | 0.156 | Acyl-CoA dehydrogenase inhibitor | 0.156 0.009 DBMET03427 | DBMET03427 | |
| 0.046 | 0.005 | 0.068 | Sodium/glucose cotransporter inhibitor | 0.068 0.004 DBMET03427 | DBMET03427 | |
| 0.177 | 0.137 | 0.309 | DNA damaging | 0.309 0.054 DBMET03427 | DBMET03427 | |
| 0.15 | 0.11 | 0.176 | Hepatoprotectant | 0.176 0.083 DBMET03427 | DBMET03427 | |
| 0.043 | 0.004 | 0.071 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.071 0.003 DBMET03427 | DBMET03427 | |
| 0.093 | 0.055 | 0.164 | Glutamate release inhibitor | 0.164 0.007 DBMET03427 | DBMET03427 | |
| 0.046 | 0.009 | 0.069 | Uridine phosphorylase inhibitor | 0.069 0.004 DBMET03427 | DBMET03427 | |
| 0.041 | 0.006 | 0.11 | Thymidine phosphorylase inhibitor | 0.11 0.003 DBMET03427 | DBMET03427 | |
| 0.049 | 0.014 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 DBMET03427 | DBMET03427 | |
| 0.048 | 0.014 | 0.126 | Fumarate hydratase inhibitor | 0.126 0.004 DBMET03427 | DBMET03427 | |
| 0.066 | 0.032 | 0.066 | Cyclin H inhibitor | |||
| 0.038 | 0.004 | 0.056 | Adenosine A3 receptor agonist | 0.056 0.004 DBMET03427 | DBMET03427 | |
| 0.062 | 0.029 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.069 0.025 DBMET03427 | DBMET03427 | |
| 0.043 | 0.012 | 0.054 | Purinergic P2X agonist | 0.054 0.008 DBMET03427 | DBMET03427 | |
| 0.038 | 0.008 | 0.047 | Purinergic P2Y15 antagonist | 0.047 0.004 DBMET03427 | DBMET03427 | |
| 0.099 | 0.069 | 0.11 | Expectorant | 0.11 0.059 DBMET03427 | DBMET03427 | |
| 0.062 | 0.033 | 0.065 | Ribonucleoside-diphosphate reductase inhibitor | 0.065 0.032 DBMET03427 | DBMET03427 | |
| 0.075 | 0.046 | 0.122 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.122 0.005 DBMET03427 | DBMET03427 | |
| 0.098 | 0.072 | 0.098 | Toll-Like receptor 4 antagonist | 0.096 0.077 DBMET03427 | ||
| 0.03 | 0.005 | 0.041 | Isoleucine-tRNA ligase inhibitor | 0.041 0.003 DBMET03427 | DBMET03427 | |
| 0.038 | 0.013 | 0.081 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.081 0.004 DBMET03427 | DBMET03427 | |
| 0.087 | 0.062 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.055 DBMET03427 | DBMET03427 | |
| 0.025 | 0.004 | 0.033 | Adenosine A2b receptor agonist | 0.033 0.003 DBMET03427 | DBMET03427 | |
| 0.133 | 0.114 | 0.135 | Nitric oxide antagonist | 0.135 0.111 DBMET03427 | DBMET03427 | |
| 0.037 | 0.019 | 0.046 | Purinergic P2Y2 antagonist | 0.046 0.012 DBMET03427 | DBMET03427 | |
| 0.027 | 0.01 | 0.035 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.035 0.007 DBMET03427 | DBMET03427 | |
| 0.039 | 0.023 | 0.072 | Inosine monophosphate dehydrogenase inhibitor | 0.072 0.008 DBMET03427 | DBMET03427 | |
| 0.022 | 0.006 | 0.037 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.037 0.004 DBMET03427 | DBMET03427 | |
| 0.022 | 0.006 | 0.032 | Purinergic P2 agonist | 0.032 0.004 DBMET03427 | DBMET03427 | |
| 0.022 | 0.006 | 0.032 | Purinergic receptor agonist | 0.032 0.004 DBMET03427 | DBMET03427 | |
| 0.128 | 0.113 | 0.128 | MAP kinase 3 inhibitor | |||
| 0.022 | 0.012 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 DBMET03427 | DBMET03427 | |
| 0.016 | 0.006 | 0.026 | Purinergic P2Y agonist | 0.026 0.004 DBMET03427 | DBMET03427 | |
| 0.099 | 0.089 | 0.145 | Alkylator | 0.145 0.049 DBMET03427 | DBMET03427 | |
| 0.016 | 0.009 | 0.027 | Purinergic P2Y1 agonist | 0.027 0.004 DBMET03427 | DBMET03427 | |
| 0.05 | 0.044 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 DBMET03427 | DBMET03427 | |
| 0.01 | 0.007 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 DBMET03427 | DBMET03427 | |
| 0.011 | 0.009 | 0.031 | Purine nucleoside phosphorylase inhibitor | 0.031 0.002 DBMET03427 | DBMET03427 | |
| 0.074 | 0.074 | 0.126 | Histamine N-methyltransferase inhibitor | 0.126 0.026 DBMET03427 | DBMET03427 | |
| 0.04 | 0.041 | 0.06 | Mannosidase inhibitor | 0.06 0.017 DBMET03427 | DBMET03427 | |
| 0.003 | 0.005 | 0.004 | Purinergic P2Y4 agonist | 0.004 0.003 DBMET03427 | DBMET03427 | |
| 0.017 | 0.018 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET03427 | DBMET03427 | |
| 0.014 | 0.019 | 0.022 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.022 0.005 DBMET03427 | DBMET03427 | |
| 0.048 | 0.052 | 0.053 | Heparanase inhibitor | 0.053 0.038 DBMET03427 | DBMET03427 | |
| 0.04 | 0.047 | 0.045 | Purinergic P2X4 antagonist | 0.045 0.034 DBMET03427 | DBMET03427 | |
| 0.04 | 0.048 | 0.044 | Carbonic anhydrase XIV inhibitor | 0.044 0.041 DBMET03427 | DBMET03427 | |
| 0.028 | 0.044 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 DBMET03427 | DBMET03427 | |
| 0.077 | 0.095 | 0.124 | Protein kinase C zeta inhibitor | 0.124 0.03 DBMET03427 | DBMET03427 | |
| 0.022 | 0.039 | 0.034 | HCV NS5B polymerase inhibitor | 0.034 0.019 DBMET03427 | DBMET03427 | |
| 0.039 | 0.056 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET03427 | DBMET03427 | |
| 0.032 | 0.051 | 0.06 | Guanylate cyclase inhibitor | 0.06 0.012 DBMET03427 | DBMET03427 | |
| 0.074 | 0.094 | 0.088 | T cell inhibitor | 0.088 0.042 DBMET03427 | DBMET03427 | |
| 0.029 | 0.053 | 0.043 | Purinergic P2Y antagonist | 0.043 0.033 DBMET03427 | DBMET03427 | |
| 0.057 | 0.084 | 0.071 | Protein kinase B gamma inhibitor | 0.071 0.056 DBMET03427 | DBMET03427 | |
| 0.018 | 0.047 | 0.036 | Arginase inhibitor | 0.036 0.026 DBMET03427 | DBMET03427 | |
| 0.071 | 0.112 | 0.091 | Cyclin-dependent kinase 9 inhibitor | 0.091 0.074 DBMET03427 | DBMET03427 | |
| 0.07 | 0.112 | 0.13 | Thioredoxin inhibitor | 0.13 0.025 DBMET03427 | DBMET03427 | |
| 0.136 | 0.183 | 0.161 | Antioxidant | 0.161 0.152 DBMET03427 | DBMET03427 | |
| 0.065 | 0.114 | 0.1 | Triose-phosphate isomerase inhibitor | 0.1 0.048 DBMET03427 | DBMET03427 | |
| 0.071 | 0.121 | 0.099 | DNA intercalator | 0.099 0.074 DBMET03427 | DBMET03427 | |
| 0.031 | 0.083 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DBMET03427 | DBMET03427 | |
| 0.044 | 0.119 | 0.077 | Interferon inducer | 0.077 0.026 DBMET03427 | DBMET03427 | |
| 0.055 | 0.139 | 0.103 | Alcohol dehydrogenase inhibitor | 0.103 0.049 DBMET03427 | DBMET03427 | |
| 0.047 | 0.138 | 0.095 | Interferon agonist | 0.095 0.033 DBMET03427 | DBMET03427 | |
| 0.084 | 0.18 | 0.131 | Cell wall synthesis inhibitor | 0.131 0.084 DBMET03427 | DBMET03427 | |
| 0.142 | 0.241 | 0.201 | Nitric-oxide synthase stimulant | 0.201 0.088 DBMET03427 | DBMET03427 | |
| 0.059 | 0.158 | 0.089 | Interleukin 5 antagonist | 0.089 0.057 DBMET03427 | DBMET03427 | |
| 0.11 | 0.213 | 0.17 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.17 0.119 DBMET03427 | DBMET03427 | |
| 0.028 | 0.142 | 0.047 | Factor IXa inhibitor | 0.047 0.042 DBMET03427 | DBMET03427 | |
| 0.027 | 0.149 | 0.045 | Cytokine production stimulant | 0.045 0.043 DBMET03427 | DBMET03427 | |
| 0.055 | 0.18 | 0.091 | Lanosterol 14 alpha demethylase inhibitor | 0.091 0.071 DBMET03427 | DBMET03427 | |
| 0.103 | 0.232 | 0.199 | Neurotrophic factor enhancer | 0.199 0.077 DBMET03427 | DBMET03427 | |
| 0.067 | 0.213 | 0.125 | Interleukin 4 antagonist | 0.125 0.079 DBMET03427 | DBMET03427 | |
| 0.074 | 0.24 | 0.127 | Mannose-6-phosphate isomerase inhibitor | 0.127 0.089 DBMET03427 | DBMET03427 | |
| 0.06 | 0.264 | 0.09 | Folate antagonist | 0.09 0.088 DBMET03427 | DBMET03427 | |
| 0.01 | 0.536 | 0.053 | Nicotinic acid receptor 1 agonist | 0.053 0.019 DBMET03427 | DBMET03427 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |